Abstract
Data normalisation is an important approach to reduce inter-subject variability in group studies, but care must be taken when choosing a normalisation strategy to not introduce further confounds or artefacts into the data. Normalisation of arterial spin labelling perfusion measurements remains challenging, especially in the context of Alzheimer’s disease, where there may be global hypoperfusion present. We propose that using the thalamus as a reference region for normalisation could improve the detectability of hypoperfusion in Alzheimer’s disease and alleviate the pseudo-hyperperfusion artefacts caused by the commonly-used strategy of normalisation using global mean perfusion. Evaluation on an Alzheimer’s disease dataset found this strategy was able to reduce coefficient of variation in perfusion measurements by around 60% and yield increases in statistical power of comparisons against healthy controls.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Clinical Medicine College, Yangzhou University granted ethical approval (decision J-2014066).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* logan.zhang{at}quantified-imaging.com
Data Availability
Data may be obtained by request to the authors of this prior work: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2022.892374/full
